Puma Biotechnology PBYI
NASDAQ PBYI
$10.00 +0.07 (+0.70%)
As of: Oct 1, 2026 · 2:48 PM EDT

Puma Biotechnology (PBYI) Total Non-Current Liabilities (2011 - 2025)

Updated

Puma Biotechnology (PBYI) posted Total Non-Current Liabilities of $85.96 million for Q4 2025, down 28.0% from $119.45 million a year earlier and down 1.9% from the prior quarter.

Analysis

Puma Biotechnology (PBYI) Total Non-Current Liabilities (2011 - 2025) Analysis & Trends

Since Q4 2011, Puma Biotechnology has reported Total Non-Current Liabilities for 57 quarters.

  • Annual Total Non-Current Liabilities has declined for five consecutive years, with a five-year compound annual growth rate of -17.4% (FY2020 to FY2025).
  • In prior years, Puma Biotechnology's Total Non-Current Liabilities was $119.45 million in FY2024 (-30.6%), $172.2 million in FY2023 (-10.8%), $193.06 million in FY2022 (-13.6%) and $223.57 million in FY2021 (-0.3%).
  • The Q4 2025 figure stands as the lowest quarterly Total Non-Current Liabilities since Q2 2017.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last 19 quarters, with an average decline of 24.3% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q1 2021, with growth of 13.7%; the weakest was Q2 2025, with a decline of 41.0%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $87.59 million (Q3 2025), $89.97 million (Q2 2025) and $97.31 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Puma Biotechnology 507.45 Mn 120.09 Mn 44.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 85.96 Mn
Sep 30, 2025 87.59 Mn
Jun 30, 2025 89.97 Mn
Mar 31, 2025 97.31 Mn
Dec 31, 2024 119.45 Mn
Sep 30, 2024 146.21 Mn
Jun 30, 2024 152.52 Mn
Mar 31, 2024 158.74 Mn
Dec 31, 2023 172.20 Mn
Sep 30, 2023 157.12 Mn
Jun 30, 2023 162.53 Mn
Mar 31, 2023 162.93 Mn
Dec 31, 2022 193.06 Mn
Sep 30, 2022 170.94 Mn
Jun 30, 2022 168.54 Mn
Mar 31, 2022 187.94 Mn
Dec 31, 2021 223.57 Mn
Sep 30, 2021 231.19 Mn
Jun 30, 2021 225.61 Mn
Mar 31, 2021 236.70 Mn
API Access

Puma Biotechnology Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PBYI&period=max&api_key=YOUR_API_KEY